Research Frontiers (REFR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 354 | 490 | 313 | 312 | 164 |
| Cost of Goods | 455 | 477 | 633 | 665 | 543 |
| Gross Profit | -101 | 13 | -320 | -352 | -379 |
| Operating Expenses | 586 | 606 | 783 | 818 | 678 |
| Operating Income | -232 | -116 | -470 | -505 | -514 |
| Other Income | 65 | 22 | 27 | 26 | 42 |
| Pre-tax Income | -167 | -94 | -443 | -480 | -472 |
| Net Income Continuous | -167 | -94 | -443 | -480 | -472 |
| Net Income | $-167 | $-94 | $-443 | $-480 | $-472 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.01 | -0.03 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.01 | -0.03 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.00 | -0.01 | N/A | N/A |
| EBITDA(a) | $-189 | $-74 | $-428 | $-463 | $-471 |